Pacific Biosciences of California, Inc. Cash and Restricted Cash
Pacific Biosciences of California, Inc. (PACB) had Cash and Restricted Cash of $62.61 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-06
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $62.61M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $57.86M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $65.26M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $58.30M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $62.61M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $57.86M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $65.26M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $58.30M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $56.63M 10-Q · filed 2026-08-06 | |
| 2025-03-31 | $60.73M 10-Q · filed 2026-05-08 | |
| 2024-12-31 | $57.59M 10-Q · filed 2026-08-06 | |
| 2024-09-30 | $80.20M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $101.79M 10-Q · filed 2025-08-07 | |
| 2024-03-31 | $79.37M 10-Q · filed 2025-05-12 | |
| 2023-12-31 | $182.63M 10-K · filed 2026-02-25 | |
| 2023-09-30 | $388.37M 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $212.01M 10-Q · filed 2024-08-09 | |
| 2023-03-31 | $357.06M 10-Q · filed 2024-05-09 | |
| 2022-12-31 | $328.31M 10-K · filed 2026-02-25 | |
| 2022-09-30 | $307.65M 10-Q · filed 2023-11-03 | |
| 2022-06-30 | $313.67M 10-Q · filed 2023-08-04 | |
| 2022-03-31 | $434.06M 10-Q · filed 2023-05-04 | |
| 2021-12-31 | $465.82M 10-K · filed 2025-03-17 | |
| 2021-09-30 | $430.45M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $463.09M 10-Q · filed 2022-08-08 | |
| 2021-03-31 | $936.73M 10-Q · filed 2022-05-06 | |
| 2020-12-31 | $85.95M 10-K · filed 2024-02-28 | |
| 2020-09-30 | $72.53M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $46.84M 10-Q · filed 2021-08-06 | |
| 2020-03-31 | $72.86M 10-Q · filed 2021-05-06 | |
| 2019-12-31 | $33.93M 10-K · filed 2023-02-28 | $33.63M 10-K · filed 2020-02-28 |
| 2019-09-30 | $37.08M 10-Q · filed 2020-11-03 | |
| 2019-06-30 | $34.36M 10-Q · filed 2020-08-06 | |
| 2019-03-31 | $42.70M 10-Q · filed 2020-05-08 | |
| 2018-12-31 | $33.93M 10-K · filed 2022-02-28 | $23.34M 10-K · filed 2019-02-26 |
| 2018-09-30 | $42.56M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $27.56M 10-Q · filed 2019-08-06 | |
| 2018-03-31 | $29.96M 10-Q · filed 2019-05-03 | |
| 2017-12-31 | $23.64M 10-K · filed 2022-02-28 | $21.01M 10-Q · filed 2018-05-02 |
| 2017-09-30 | $30.43M 10-Q · filed 2018-11-05 | |
| 2017-06-30 | $40.98M 10-Q · filed 2018-08-03 | |
| 2017-03-31 | $33.48M 10-Q · filed 2018-05-02 | |
| 2016-12-31 | $21.27M 10-K · filed 2020-02-28 | |
| 2015-12-31 | $38.13M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |